[PDF] Top 20 FORMULATION AND EVALUATION OF LOSARTAN POTASSIUM FLOATING TABLETS: OPTIMIZATION BY 23 FACTORIAL DESIGN
Has 10000 "FORMULATION AND EVALUATION OF LOSARTAN POTASSIUM FLOATING TABLETS: OPTIMIZATION BY 23 FACTORIAL DESIGN" found on our website. Below are the top 20 most common "FORMULATION AND EVALUATION OF LOSARTAN POTASSIUM FLOATING TABLETS: OPTIMIZATION BY 23 FACTORIAL DESIGN".
FORMULATION AND EVALUATION OF LOSARTAN POTASSIUM FLOATING TABLETS: OPTIMIZATION BY 23 FACTORIAL DESIGN
... release floating tablets of losartan potassium were formulated employing HPMC K15M (50 %) as matrix forming polymer, sodium bicarbonate as gas generating agent and beeswax and ethyl cellulose ... See full document
13
FORMULATION AND EVALUATION OF CAPTOPRIL FLOATING TABLETS EMPLOYING A NEW MODIFIED STARCH – OPTIMIZATION BY 23 FACTORIAL DESIGN
... The required quantities of captopril, Cross linked starch-urea, starch acetate, lactose and sodium bicarbonate were thoroughly mixed in a dry mortar by following geometric dilution technique. Beeswax was melted in a dry ... See full document
13
FORMULATION DEVELOPMENT OF VALSARTAN TABLETS: OPTIMIZATION BY 23 FACTORIAL DESIGN, IN VITRO AND PHARMACOKINETIC EVALUATION
... tablet formulation with NLT 85% dissolution in 10 min could be formulated employing βCD at 1:3 ratio of drug: β CD, Crospovidone at ...valsartan tablets (Fopt1) were formulated employing the optimized ... See full document
12
FORMULATION AND EVALUATION OF LOSARTAN FLOATING TABLETS EMPLOYING A NEW MODIFIED STARCH – OPTIMIZATION BY 23 FACTORIAL DESIGN Swathi G * , K. P. R. Chowdary and A.Muralidhar RaoDOWNLOAD/VIEW
... in formulation and handling of these ...uncertain. Formulation of floating drug delivery systems is a useful approach to avoid this variability with increased gastric retention time of the drug ... See full document
8
FORMULATION, OPTIMIZATION AND EVALUATION OF CONTROLLED RELEASE MICROSPHERES OF LOSARTAN POTASSIUM
... for 10 min with the help of a magnetic stirrer. A w/o emulsion was formed. The temperature of the oil bath was raised to 95°C. Spherical highest percentage yielding microspheres with moderate aggregation at (95°C) and ... See full document
24
FORMULATION AND EVALUATION OF IMMEDIEATE RELEASE SUBLINGUAL TABLET OF LOSARTAN POTASSIUM USING FACTORIAL DESIGN
... Losartan potassium is mainly used to treat high blood pressure, it is a angiotensin II receptor ...of losartan potassium containing super disintegrants via direct compression, to improve ... See full document
10
FORMULATION AND EVALUATION OF MOUTH DISSOLVING FILMS OF LOSARTAN POTASSIUM USING 32 FACTORIAL DESIGN
... mucosa. Losartan potassium is an angiotensin II receptor antagonist used to treat primarily high blood pressure besides other disease conditions 7 ...of Losartan is good after oral administration due ... See full document
10
FORMULATION AND EVALUATION OF FLOATING ORAL IN SITU GELLING SYSTEM OF LOSARTAN POTASSIUM
... ABSTRACT: Losartan potassium is used to treat hypertension, and it protects the kidneys from diabetic ...of floating oral in-situ gel. Present research performed on losartan potassium ... See full document
9
Formulation and optimization of carbamazepine floating tablets by 23 - factorial design employing Starch-Urea-Borate: A new floating polymer
... for floating tablets based on gas generation ...prepared tablets was slow and spread over more than 24 h and depended on the composition of the matrix ...prepared floating tablets. ... See full document
11
FORMULATION AND IN VITRO EVALUATION OF GASTRORETENTIVE BILAYER FLOATING TABLETS OF LOSARTAN POTASSIUM
... IR tablets to optimize the super disintegrant before performing the dissolution studies for bilayer tablets ...bilayer floating tablets (BFTs) were then placed into 900ml of ...for ... See full document
8
FORMULATION OF RITONAVIR TABLETS: OPTIMIZATION BY 22 FACTORIAL DESIGN
... is optimization of ritonavir tablet formulation employing βCD and Soluplus by 2 2 factorial ...design. Formulation of ritonavir tablets with NLT 85% dissolution in 15 min ... See full document
9
FORMULATION OF TELMISARTAN TABLETS EMPLOYING βCD, CROSPOVIDONE, POLOXAMER OPTIMIZATION BY 23 FACTORIAL DESIGN
... For optimization of Telmisartan tablets as per 2 3 factorial design the βCD, crospovidone (superdisintegrant) and Poloxamer188 (a non ionic surfactant) are considered as the three ...3 ... See full document
9
Formulation and evaluation of Losartan Potassium matrix tablets for oral controlled release
... to design oral controlled release matrix tablets of losartan ...potassium. Tablets were prepared by direct compression and evaluated for hardness, friability, thickness, drug content ... See full document
6
Formulation and Evaluation of Immediate Release Bilayer Tablets of Amlodipine Besylate and Losartan Potassium
... The another new drug delivery concept is the control release of drug form the dosage form where the drug is released from the dosage form in a constant manner in respect to time but without depending upon the initial ... See full document
152
FORMULATION DEVELOPMENT OF VALSARTAN TABLETS EMPLOYING ? CD, CROSPOVIDONE AND SLS: OPTIMIZATION BY 23 FACTORIAL DESIGN
... tablet formulation employing βCD, Crospovidone and SLS by 2 3 Factorial design to achieve NLT 85% dissolution in 10 ...For optimization of Valsartan tablets as per 2 3 Factorial ... See full document
9
OPTIMIZATION OF VALSARTAN TABLET FORMULATION BY 23 FACTORIAL DESIGN
... tablet formulation was optimized by 2 3 factorial design for selecting the best combinations of diluent, binder and disintegrant giving fast dissolution of the ...For formulation of valsartan ... See full document
6
Formulation and evaluation of floating microspheres of losartan potassium using sodium alginate and HPMC by solvent evaporation method
... The various formulations of the floating microspheres were subjected for drug content. 100mg of floating microspheres from all batches were accurately weighed. The microspheres were dissolved with 10ml ... See full document
7
Formulation, Development and Evaluation of Floating Microsphere of Losartan Potassium Using Natural Polymer
... of losartan and with all excipients was taken using KBr pellet ...was losartan and no interference with drug and excipients. The floating microspheres of losartan were prepared by solvent ... See full document
6
FORMULATION AND OPTIMIZATION OF BUPROPION HCl MICROSPONGES BY 23 FACTORIAL DESIGN
... the floating Bupropion HCl microsponges by 2 3 factorial ...variables. Floating lag time & % drug release were selected as independent ...the design of experiment software (Sigma tech ... See full document
11
OPTIMIZATION OF VALSARTAN TABLET FORMULATION BY 23 FACTORIAL DESIGN
... About 95% of all new potential therapeutic drugs (APIs) exhibit low and variable oral bioavailability due to their poor aqueous solubility at physiological pH and consequent low dissolution rate. These drugs are ... See full document
10
Related subjects